Abstract
Purpose
Pharmacologic conversion of atrial fibrillation and flutter (AF/AFl) is common with dofetilide. We determined whether pharmacologic conversion with dofetilide predicts long-term arrhythmia-free survival.
Methods
We retrospectively studied a cohort of 264 consecutive patients who initiated dofetilide during persistent AF/AFl between 2008 and 2013. Patients were excluded if dofetilide was discontinued prior to five doses or electrical cardioversion was performed prior to four doses. Incidence of and characteristics associated with pharmacologic conversion were determined. Patients were followed for long-term AF/AFl recurrence. Predictors of recurrence were identified using multivariate Cox modeling.
Results
Of 205 patients meeting study criteria, 92 (44.9 %) converted to sinus rhythm during dofetilide loading. Female gender, history of AFl, greater number of prior catheter ablations, shorter duration of current AF/AFl, and presentation in AFl were all associated with acute pharmacologic conversion (p = 0.001, 0.05, 0.001, 0.003, and 0.003, respectively). In multivariate modeling, longer time since first AF/AFl diagnosis (hazard ratio (HR) = 1.07 per 1-year increase, 95 % confidence interval (CI) 1.03–1.10, p < 0.001), longer duration of current AF/AFl episode (HR = 1.01 per 1-month increase, 95 % CI 1.00–1.01, p = 0.003) and greater number of failed antiarrhythmic drugs (HR = 1.43 per one drug increase, 95 % CI 1.20–1.70, p < 0.001) were independently associated with shorter time to AF/AFl recurrence. Pharmacologic conversion was not significantly associated with time to AF/AFl recurrence (HR = 0.79, 95 % CI 0.57–1.10, p = 0.2).
Conclusions
Acute pharmacologic conversion of persistent AF/AFl to sinus rhythm frequently occurs during dofetilide loading. Nevertheless, acute pharmacologic conversion does not predict long-term arrhythmia control, which was moderate at best.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- AFl:
-
Atrial flutter
References
Corley, S. D., Epstein, A. E., DiMarco, J. P., Domanski, M. J., Geller, N., Greene, H. L., et al. (2004). Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation, 109(12), 1509–1513.
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. (2002). A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. The American Journal of Medicine, 113(5), 359–364.
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1987). Atrial fibrillation: a major contributor to stroke in the elderly. the Framingham Study. Archives of Internal Medicine, 147(9), 1561–1564.
Baman, T. S., Ilg, K. J., Gupta, S. K., Good, E., Chugh, A., Jongnarangsin, K., et al. (2010). Mapping and ablation of epicardial idiopathic ventricular arrhythmias from within the coronary venous system. Circulation. Arrhythmia and Electrophysiology, 3(3), 274–279.
Savelieva, I., & Camm, J. (2008). Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace, 10(6), 647–665.
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. The New England Journal of Medicine, 352(18), 1861–1872.
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., et al. (2000). Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation, 102(19), 2385–2390.
Pedersen, O. D., Bagger, H., Keller, N., Marchant, B., Kober, L., & Torp-Pedersen, C. (2001). Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 104(3), 292–296.
Banchs, J. E., Wolbrette, D. L., Samii, S. M., Penny-Peterson, E. D., Patel, P. P., Young, S. K., et al. (2008). Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. Journal of Interventional Cardiac Electrophysiology, 23(2), 111–115.
Cotiga, D., Arshad, A., Aziz, E., Joshi, S., Koneru, J. N., & Steinberg, J. S. (2007). Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing and Clinical Electrophysiology : PACE, 30(12), 1527–1530.
Prystowsky, E. N., Freeland, S., Branyas, N. A., Rardon, D. P., Fogel, R. I., Padanilam, B. J., et al. (2003). Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14(12 Suppl), S287–S290.
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm, 9(4), 632–696. e621.
Tikosyn(R) [package insert]. Pfizer Inc., New York, NY; January 2014. http://labeling.pfizer.com/ShowLabeling.aspx?id=639. Accessed 29 Apr 2014.
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA, 285(22), 2864–2870.
Borgeat, A., Goy, J. J., Maendly, R., Kaufmann, U., Grbic, M., & Sigwart, U. (1986). Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology, 58(6), 496–498.
Bianconi, L., Mennuni, M., Lukic, V., Castro, A., Chieffi, M., & Santini, M. (1996). Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. Journal of the American College of Cardiology, 28(3), 700–706.
Di Benedetto, S. (1997). Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology, 80(4), 518–519.
Kochiadakis, G. E., Igoumenidis, N. E., Solomou, M. C., Kaleboubas, M. D., Chlouverakis, G. I., & Vardas, P. E. (1999). Efficacy of amiodarone for the termination of persistent atrial fibrillation. The American Journal of Cardiology, 83(1), 58–61.
Kerin, N. Z., Faitel, K., & Naini, M. (1996). The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Archives of Internal Medicine, 156(1), 49–53.
Tieleman, R. G., Gosselink, A. T., Crijns, H. J., van Gelder, I. C., van den Berg, M. P., de Kam, P. J., et al. (1997). Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. The American Journal of Cardiology, 79(1), 53–57.
Singh, S., Saini, R. K., DiMarco, J., Kluger, J., Gold, R., & Chen, Y. W. (1991). Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. The American Journal of Cardiology, 68(11), 1227–1230.
Hohnloser, S. H., van de Loo, A., & Baedeker, F. (1995). Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Journal of the American College of Cardiology, 26(4), 852–858.
Crijns, H. J., Van Gelder, I. C., Van Gilst, W. H., Hillege, H., Gosselink, A. M., & Lie, K. I. (1991). Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. The American Journal of Cardiology, 68(4), 335–341.
Crijns, H. J., Gosselink, A. T., & Lie, K. I. (1996). Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group. Cardiovascular Drugs and Therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy, 10(2), 145–152.
Le Heuzey, J. Y., De Ferrari, G. M., Radzik, D., Santini, M., Zhu, J., & Davy, J. M. (2010). A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. Journal of Cardiovascular Electrophysiology, 21(6), 597–605.
Pamukcu, B., & Lip, G. Y. (2010). Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study. Expert Opinion on Pharmacotherapy, 11(17), 2775–2778.
Feld, G. K., & Cha, Y. (1997). Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics, 2(3), 195–203.
Malhotra, R., Bilchick, K. C., & DiMarco, J. P. (2014). Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy. The American Journal of Cardiology, 113(3), 475–479.
Wijffels, M. C., Kirchhof, C. J., Dorland, R., & Allessie, M. A. (1995). Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 92(7), 1954–1968.
Morillo, C. A., Klein, G. J., Jones, D. L., & Guiraudon, C. M. (1995). Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation, 91(5), 1588–1595.
Manning, W. J., Silverman, D. I., Katz, S. E., Riley, M. F., Come, P. C., Doherty, R. M., et al. (1994). Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. Journal of the American College of Cardiology, 23(7), 1535–1540.
Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997). Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 96(4), 1180–1184.
Allessie, M., Ausma, J., & Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54(2), 230–246.
Everett, T. H., Wilson, E. E., Verheule, S., Guerra, J. M., Foreman, S., & Olgin, J. E. (2006). Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. American Journal of Physiology. Heart and Circulatory Physiology, 291(6), H2911–H2923.
Acknowledgments
This work was supported in part by the F. Harlan Batrus Research Fund and the Susan and Murray Bloom Fund.
Author contributions
Khurshid—design, data collection and analysis, drafting, and approval of article
Akerman—design, data collection, and approval of article
Man—design, data collection, and approval of article
Supple—critical revision and approval of article
Dixit—critical revision and approval of article
Epstein—critical revision and approval of article
Marchlinski—critical revision and approval of article
Frankel—design, data collection and analysis, drafting, and approval of article
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khurshid, S., Akerman, S., Man, J.P. et al. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival. J Interv Card Electrophysiol 42, 117–124 (2015). https://doi.org/10.1007/s10840-015-9974-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-015-9974-7